No Data
No Data
FDA Solicits Public Comments On Use Of Cannabis-derived Products In Veterinary Medicine
Legal Cannabis May Be Boosted by Alcohol Warning From Surgeon General: Analyst
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts?
Cannabis Sector Limps Into 2025 Because 'the Gold Rush Is Over'
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.18